Drug Designing: Open Access
Open Access

Department of Pharmacy, College of Health Science, Mizan-Tepi University, Mizan-Aman, Ethiopia

Publications

• Research Article   
  Potential Drug Candidates for the Treatment of Coronavirus Disease 2019 (COVID 19): Current Clinical Trials and their Interpretations
  Author(s): Jafer Siraja*
  
  The occurrence of the coronavirus disease 2019 (COVID-19) is formally recognized as a severe acute respiratory syndrome-related coronavirus (SARS-CoV-2) and characterized as a universal public health problem. Coronavirus disease 2019 (COVID-19) infects the lower respiratory system to cause viral pneumonia, and also leads to multiple organ damage including kidney, liver and etc. The coronavirus disease 2019 is spread and transmits through human-to-human by means of droplets, feco-oral, and direct contact. Applying the protective mechanism is the only option to control COVID-19 infection due to the absence of approved antiviral treatment or vaccine for the prevention and treatment of COVID-19. Therefore, developing a safe and effective therapeutic agent is necessary to overcome the overcoming potential impact of coronavirus disease in 2019 in the world. This review .. View More»
  DOI: 10.35248/2169-0138.20.9.167

  Abstract HTML PDF